| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3280754 | Arab Journal of Gastroenterology | 2015 | 6 Pages |
Abstract
Interleukin-28B polymorphism could be a possible predictor of response to pegylated interferon/ribavirin therapy (PEG-IFN/RBV). Furthermore, co-infection with EBV did not affect the response to IFN-based therapy in HCV-infected patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Abdel-Rahman N. Zekri, Dina Abdullah, Ahmed Osman, Mahmoud N. El-Rouby, Naglaa Zayed, Gamal Esmat, Wafaa Elakel, Hanan Abdel Hafez,